肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

免疫激活和调节机制:来自黑色素瘤的教训

Mechanisms of immune activation and regulation: lessons from melanoma

原文发布日期:2022-02-01

DOI: 10.1038/s41568-022-00442-9

类型: Review Article

开放获取: 否

英文摘要:

摘要翻译: 

原文链接:

文章:

免疫激活和调节机制:来自黑色素瘤的教训

Mechanisms of immune activation and regulation: lessons from melanoma

原文发布日期:2022-02-01

DOI: 10.1038/s41568-022-00442-9

类型: Review Article

开放获取: 否

 

英文摘要:

Melanoma, a skin cancer that develops from pigment cells, has been studied intensively, particularly in terms of the immune response to tumours, and has been used as a model for the development of immunotherapy. This is due, in part, to the high mutational burden observed in melanomas, which increases both their immunogenicity and the infiltration of immune cells into the tumours, compared with other types of cancers. The immune response to melanomas involves a complex set of components and interactions. As the tumour evolves, it accumulates an increasing number of genetic and epigenetic alterations, some of which contribute to the immunogenicity of the tumour cells and the infiltration of immune cells. However, tumour evolution also enables the development of resistance mechanisms, which, in turn, lead to tumour immune escape. Understanding the interactions between melanoma tumour cells and the immune system, and the evolving changes within the melanoma tumour cells, the immune system and the microenvironment, is essential for the development of new cancer therapies. However, current research suggests that other extrinsic factors, such as the microbiome, may play a role in the immune response to melanomas. Here, we review the mechanisms underlying the immune response in the tumour and discuss recent advances as well as strategies for treatment development.

 

摘要翻译: 

黑色素瘤是一种由色素细胞发展而成的皮肤癌,已被深入研究,尤其是在针对肿瘤的免疫反应方面,并作为免疫疗法开发的模型。部分原因在于,与其他类型癌症相比,黑色素瘤具有较高的突变负荷,这既增强了其免疫原性,也促进了免疫细胞向肿瘤内部的浸润。对黑色素瘤的免疫反应涉及一系列复杂的组分和相互作用。随着肿瘤的进化,它会积累越来越多的遗传和表观遗传改变,其中一些改变有助于肿瘤细胞的免疫原性和免疫细胞的浸润。然而,肿瘤的进化也促使耐药机制的发展,进而导致肿瘤的免疫逃逸。理解黑色素瘤肿瘤细胞与免疫系统之间的相互作用,以及黑色素瘤肿瘤细胞、免疫系统和微环境内部的不断变化,对于开发新的癌症疗法至关重要。然而,当前研究表明,其他外部因素,如微生物组,可能在黑色素瘤的免疫反应中发挥作用。在此,我们综述了肿瘤中免疫反应的潜在机制,并讨论了最新进展以及治疗开发的策略。

 

原文链接:

Mechanisms of immune activation and regulation: lessons from melanoma

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……